EU panel gives a positive opinion for AstraZeneca’s cancer drug
AstraZeneca’s drug for treating limited-stage small cell lung cancer got a recommendation for approval from an EU regulator panel, according to the British-Swedish.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
AstraZeneca’s drug for treating limited-stage small cell lung cancer got a recommendation for approval from an EU regulator panel, according to the British-Swedish.
A $549.6 million observatory, situated on a mountaintop in Cerro Pachón in Chile, will start operations by October in an attempt to provide.
Global researchers, led by Australia’s Macquarie University, in a bid to re-engineer life in a laboratory, have completed the world’s first synthetic yeast.
By Bharti Jayshankar February 1, 2025: A study from the University of Minnesota has revealed a connection between exclusionary discipline (ED) practices in.
HQ Team February 1, 2025: A nine-hour film titled Don’t Look Down, released recently, addresses the problem of smartphone addiction among pre-teens and.
Bharti Jayshankar February 1, 2025: A study published in JAMA Network Open reveals that heavy cannabis use may impair brain function during critical.
Bharti Jayshankar January 31, 2025: A recent meta-analysis published in BMJ Nutrition Prevention & Health reveals that more than 45% of patients with.
Researchers at Cambridge are developing implants that could help repair damaged brain cells and treat diseases like Parkinson’s.
Vertex Pharmaceuticals Inc.’s non-opioid analgesic to treat moderate to severe acute pain in adults got approval from the US drug regulator.
Britain’s National Health Service will provide a gene therapy that may cure sickle cell disease for patients 12 years and older, according to.
We use cookies to improve your experience on our site. By using our site, you consent to cookies.
Manage your cookie preferences below:
Essential cookies enable basic functions and are necessary for the proper function of the website.
Statistics cookies collect information anonymously. This information helps us understand how visitors use our website.
Google Analytics is a powerful tool that tracks and analyzes website traffic for informed marketing decisions.
Service URL: policies.google.com